NAV on (27 Apr 2026 )
₹18.84 ▲
(+2.33%)
Fund Size
₹1976.86 Crores
1Y Returns
15.69 %
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
HDFC Asset Management Company Ltd.
Launch Date
September 14, 2023
Fund Manager
Mr. Nikhil Mathur
Initial Price
10
AUM Fund
1976.86 Cr
Min investment
Rs 100
Expense Ratio
0.94%
"Daily - Rs. 100 and in multiples of Re. 1 thereafter. Minimum number of installments 6. Weekly - Rs. 100 and in multiples of Re. 1 thereafter. Minimum number of installments 6. Monthly - Rs. 100 and in multiples of Re. 1 thereafter. Minimum number of installments 6. Quarterly - Rs. 1,500-2,999 and in multiples of Re. 1 thereafter. Minimum number of installments 4.Quarterly - Rs. 3,000 and above and in multiples of Re. 1 thereafter. Minimum number of installments 4.Half Yearly - Rs. 2,500 and above and in multiples of Re. 1 thereafter. Minimum number of installments 2.Yearly - Rs. 5,000 and above and in multiples of Re. 1 thereafter. Minimum number of installments 1."
"In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment."
1 Month
+6.37%
6 Months
+6.28%
1 Year
+15.69%
2 Years (CAGR)
+22.23%
3 Years (CAGR)
NA
5 Years (CAGR)
NA
| Equity / Mid Cap funds | 1Y | 3Y | Fund Size (Cr) |
|---|---|---|---|
| 15.69% | 0.00% | ₹1976.86 | |
| 15.69% | 0.00% | ₹1976.86 | |
| 14.33% | 0.00% | ₹1976.86 | |
| 14.33% | 0.00% | ₹1976.86 | |
| 13.23% | 0.00% | ₹556.42 |
Q: What is the current NAV of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW?
A: The latest NAV of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW is ₹ 18.84 as on 27 Apr 2026.
Q: What type of mutual fund is HDFC Pharma and Healthcare Fund - Direct Plan - IDCW?
A: HDFC Pharma and Healthcare Fund - Direct Plan - IDCW is a 'Equity - Pharma' type mutual fund managed by 'HDFC Asset Management Company Ltd.'.
Q: What is the expense ratio of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW?
A: The expense ratio of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW is 0.94%, which impacts overall returns.
Q: Who manages HDFC Pharma and Healthcare Fund - Direct Plan - IDCW?
A: HDFC Pharma and Healthcare Fund - Direct Plan - IDCW is managed by Mr. Nikhil Mathur, who oversees investment strategy and portfolio decisions.
Q: Is HDFC Pharma and Healthcare Fund - Direct Plan - IDCW a good investment?
A: HDFC Pharma and Healthcare Fund - Direct Plan - IDCW may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.
Q: What is the exit load of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW?
A: The exit load of HDFC Pharma and Healthcare Fund - Direct Plan - IDCW is "In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.", applicable if redeemed within the specified period.
Q: How is HDFC Pharma and Healthcare Fund - Direct Plan - IDCW taxed?
A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback